The issues faced by millions of people living with and after cancer need to be identified and addressed, a conference has heard.
According to the UK’s National Cancer Research Institute (NCRI), there is currently very little research on the proble...
5 years ago
Combining a chemotherapy drug with immunotherapy yielded “promising” results for people with relapsed or refractory acute myeloid leukaemia (AML), a US-based phase II study has reported.
The study, published in the journal Cancer Discovery last we...
5 years ago
